January 6, 2023

“Best practices” conference is Feb 9-10

EduCon is the conference for keeping your team members current and compliant, and it’s coming up February 9-10, 2023. Best of all, you can earn up to 12 CE hours.

January 6, 2023

APC appeals USP <797> provisions

APC has notified USP that it will appeal certain provisions of the revised USP Chapter <797> and has requested 30 days to file the substance of that appeal.

January 6, 2023

A HUGE milestone: 100 PFMs

We launched our new "company" membership category in March 2022. As a result, we've grown from about 900 individual members last March to nearly 4,000 total members today—and we're still growing.

January 6, 2023

We salute our 2022 major investors

We’re deeply grateful to all who made investments in APC in 2022

December 21, 2022

Bylaws changes affect APC officer election, titles

APC members recently approved bylaws amendments to eliminate the office of president and change the way Alliance officers are elected.

December 21, 2022

APC submits comments to FDA on DTE

APC recently submitted a comment letter to FDA following the agency's communications to NABP stating that Thyroid USP was a biologic and therefore ineligible for compounding.

December 21, 2022

Welcome newest PFMs

We’re pleased to welcome our newest PFM members to the fold, bringing the total to 95 pharmacies and facilities that have joined APC as PFMs.

December 21, 2022

CC: December 21, 2022

Compounding Connections: December 21, 2022

December 16, 2022

Leaders talk adverse events reporting with FDA

In a listening session this week with FDA officials, APC leaders outlined a draft of an adverse events reporting framework for 503As that could be incorporated into legislation in the next Congress.

December 16, 2022

CC: December 16, 2022

Compounding Connections: December 16, 2022

« Newer EntriesOlder Entries »